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THERE IS still doubt as to the best the addition of immediate post-operative
form of treatment for primary cancer radiotherapy does not confer an advan-
of the breast. However, an analysis of tage over a watching policy, in which
randomized comparisons of various meth- radiotherapy is given only when indicated
ods of local treatment have allowed 3 by local recurrence (Roberts et al., 1973;
broad conclusions (Sutherland, 1974). Forrest et al., 1974; Murray, 1974).
These are: However, the relevant trials are not
1. When surgical treatment includes yet mature and only one includes informa-
resection of the breast and axillary nodes tion on the histological state of the
in continuity (radical mastectomy), the axillary nodes based on pectoral node
addition ofimmediate post-operative radi- biopsy (Forrest et al., 1974).
cal radiotherapy to skin flaps and regional The failure of the type oflocal therapy
node areas does not confer any advantage to influence the results of treatment of
in survival or local recurrence rates primary breast cancer is due to the fact
compared with a watching policy, in that dissemination has taken place by
which the use of radiotherapy is delayed the time the patient first discovers her
until indicated by local recurrence (Cole, lesion. At least 7000 of women with
1964; Easson, 1968a; Fisher et al., so-called early (clinical stage I and II)
1970). disease will die from metastases within
2. If immediate radical radiotherapy 20 years (Easson, 1968b; Brinkley and
is to be given post-operatively, there is Haybittle, 1975). In these women sur-
no advantage in performing surgical pro- vival is unlikely to be influenced by
cedures which are more extensive than the extent or type of local treatment.
a simple (total) mastectomy (Brinkley Conversely, for those whose disease is
and Haybittle, 1966, 1971). truly confined to the breast, removal
3. Simple mastectomy and immediate of the breast alone should result in cure.
radical radiotherapy give results as good It is our belief that histological evidence
as those from radical surgery alone (Kaae of the state of the axillary nodes is cur-
and Johansen, 1968; Hamilton, Langlands rently the best guide to these two types
and Prescott, 1974). of disease.
Also, there is increasing evidence that We are convinced that, except as
when a simple mastectomy is performed, methods to obtain axillary node histology,
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radical operations have served their time PATIENTS AND METHODS
as routine procedures for all patients The trials were designed by a steering
with primary breast cancer of clinical committee composed mainly of representa-
stages I and II. Studies indicating that tives of general surgeons and radiotherapists
nodes for sampling can be obtained in the South East Region of Scotland.
during a simple mastectomy, without Protocols were drawn up and circulated.
formal dissection of the axilla (Roberts et Thirty-one surgeons and 6 radiotherapists
at., 1973; Cant, Shivas and Forrest, agreed to take past. Both trials commenced,
1975), have further convinced us that a with MRC support, on 1 April 1975. They
simple (total) mastectomy is the most
extensive operation which should gener- Trial I
ally be used. Treatment policies based Admission.-Patients of TNM clinical
on this information are, in the short stages I and II in whom histological examina-
term, giving results equivalent to those tion of a pectoral node taken at simple
following more radical techniques (Forrest mastectomy showed no evidence of met-
et al., 1974). astatic tumour or in whom no node could be
We therefore decided that two con- found for examination.
trolled, randomized trials should be Exclusions.-Patients over 70 years of
mounted in Edinburgh where for many age, with previous malignant disease, with
years the orthodox primary treatment previous bilateral oophorectomy or hys-
for clinical stages I and II breast cancer terectomy or in poor general condition.
has been simple mastectomy and post- Stratification.-According to clinical size
operative radical radiother
. of tumour, site of tumour and menstrual operative radical radiotnerapy. status.
These trials are designed to answer Treatment.-Randomization within 12
two questions: subgroups for radical post-operative radio-
therapy(4250-4500radsto max. in 10fractions
1. If histological examination of those over 4 weeks) or for a watching policy
nodes which are available at the (no immediate post-operative radiotherapy).
time of simple mastectomy without In the event of previously palpable nodes
dissecting the axilla (nodes of the enlarging or new nodes appearing in the
pectoral or 'axillary-tail' group) watched group of patients, these would not shcowsralevidence o finvasiron b be taken to mean failure of treatment. shows no evidence ofinva by Histological confirmation ofnodal involve- tumour, doesimmediate post-opera- ment would lead to the patients being alloca-
tiveradical radiotherapy conferany ted as in trial II to receive either radical
advantage over a watching policy? radiotherapy or radical radiotherapy plus
2. If the histological examination of chemotherapy using 5-fluorouracil.
the nodes reveals metastatic disease, Assessment.-Morbidity, disease-free in-
does the addition of systemic terval, survival.
therapy to conventional local
treatment improve survival rates Trial II
(Fisher et al., 1975)? Admission.-(i) Patients with tumours
ofTNM clinical stages I and II who, following
As the objective of the second trial histological confirmation of involvement of a
is to determine the effect of additional pectoral node, have received radical radio-
systemic therapy in disease of likely therapy following simple mastectomy. (ii)
incurability, patients with clinically locall Patients with tumours of TNM clinical
advaced stag II) dieasehavebee stage III who have been treated either by advanced (stage III) disease have been radical radiotherapy alone or by simple included. For them the conventional mastectomy and radical radiotherapy accord-
local treatment is either simple mastec- ing to the operability ofthe lesion.
tomy and post-operative radiotherapy or Exclusions.-Patients over 70 years of
radiotherapy alone. age, with previous malignancy, with previous630 BREAST TRIAL COMMITTEE
oophorectomy or hysterectomy, or who are
considered unfit for chemotherapy.
Stratification.-According to the stage
(stage II histological, stage III operated,
stage III not operated) and the menstrual
status.
Treatment.-Randomization within 9 sub-
groups for additional systemic therapy or
inclusion in a matched control group when
no additional therapy is given. Initially,
the form of additional systemic therapy
is chemotherapy, 5-fluorouracil, 700 mg/M2
i.v. every 4 weeks for 12 injections.
COMMENT
Within these trials, all patients with
cancer of the breast of clinical stages I
and II and stage III (operable) are
treated by one standard operation, name-
ly, simple (total) mastectomy. In the
case of those with clinical stages I and II
disease, the decision for subsequent addi-
tional treatment depends upon the histo-
logical findings in those nodes (pectoral)
which are either removed with the
axillary tail of the breast or identified
during its dissection. While planned
around the orthodox Edinburgh treat-
ment of simple mastectomy and imme-
diate post-operative radical radiotherapy,
the design of these trials could be applied
to other standard treatment policies, e.g.,
en bloc resection of the breast and axillary
nodes.
In these trials we are seeking to
reduce the extent of local therapy, and
therefore morbidity, for disease which, by
histological assessment of nodal invasion,
is shown to be confined to the breast.
Local treatment is not enough when
proof of local advancement is obtained
either on clinical examination (stage III)
or by examination ofthe removed pectoral
nodes (histological stage II). In these
circumstances improved survival rates
are likely to be achieved only by the
addition of systemic therapy to conven-
tional treatment.
We are grateful for the help of Dr
Mary Douglas, Mr A. J. Duff, Mr G.
Meikle, Dr M. M. Roberts and Professor
Sir Michael Woodruff who were members
of the initial steering committee.
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